Foscarbidopa; Foslevodopa Patent Expiration
Foscarbidopa; Foslevodopa was first introduced by Abbvie Inc
Foscarbidopa; Foslevodopa Patents
Given below is the list of patents protecting Foscarbidopa; Foslevodopa, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vyalev | US10174061 | Carbidopa and L-dopa prodrugs and methods of use | Oct 21, 2035 | Abbvie |
| Vyalev | US10730895 | Carbidopa prodrug | Oct 21, 2035 | Abbvie |
| Vyalev | US9446059 | Carbidopa and L-dopa prodrugs and methods of use | Oct 21, 2035 | Abbvie |
Foscarbidopa; Foslevodopa's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List